Sign up to get notified if we do in the future.
We guarantee the lowest price on all of our prescription products. If you find your medications cheaper at any other recognized licensed mail order pharmacy, we will not only match their price, we will beat it by 25% of the difference. It is our 125% price match guarantee!
Example: If you find a product on Canada Drugs Direct for $50.00 and find the same product for $40.00 at another mail order pharmacy, we will provide you with a $12.50 discount, bringing your total to $37.50.
To get the discount please make sure to mention the price match to the customer service team when they call to collect payment for your order. Or call toll free at 1-888-904-8467 to place the order through the phone.
Terms & Conditions of Program
A generic drug is a copy of the brand-name drug with the same dosage, safety, strength, quality, consumption method, performance, and intended use. Before generics become available on the market, the generic company must prove it has the same active ingredients as the brand-name drug and works in the same way and in the same amount of time in the body.
The only differences between generics and their brand-name counterparts is that generics are less expensive and may look slightly different (eg. different shape or color), as trademarks laws prevent a generic from looking exactly like the brand-name drug.
Generics are less expensive because generic manufacturers don't have to invest large sums of money to develop a drug. When the brand-name patent expires, generic companies can manufacture a copy of the brand-name and sell it at a substantial discount.
Pomalyst (Pomalidomide) is a third-generation immunomodulatory drug that can modify or regulate the functioning of the immune system. This medication is used to treat multiple myeloma and AIDS-related Kaposi sarcoma. It is typically taken in combination with another medicine, dexamethasone, to treat adults with multiple myeloma who have previously received at least 2 medicines, including a proteasome inhibitor and lenalidomide.
Fact Table |
|
Formula |
C13H11N3O4 |
License |
US FDA, US DailyMed, EU EMA |
Bioavailability |
73% |
Legal status |
Rx-Only |
Chemical Name |
Pomalidomide |
Elimination half-life |
7.5 hours |
Dosage (Strength) |
4mg |
Pregnancy |
it may cause birth defects or death to an unborn baby |
Brands |
Pomalyst |
Protein binding |
12–44% |
PubChem CID |
134780 |
MedlinePlus |
a613030 |
ChEBI |
72690 |
ATC code |
L04AX06 |
DrugBank |
DB08910 |
KEGG |
D08976 |
Routes of administration |
By mouth |
The initial dosage for adults with multiple myeloma is 4 milligrams (mg) once daily. It is typically taken on days 1 to 21 of a 28-day cycle, with this schedule repeated every 28 days. A healthcare provider may adjust this dosage as needed, based on tolerance and effectiveness. When taking Pomalyst, follow the directions on the prescription label carefully. If any part of the directions is unclear, consult a healthcare provider.
Pomalidomide is the active ingredient in Pomalyst. Along with the active ingredient, Pomalyst capsules may contain several inactive ingredients.
Pomalyst should not be used by pregnant women or women who may become pregnant during treatment. It is critical that patients using Pomalyst take appropriate measures to prevent pregnancy during their treatment and for four weeks after stopping the medication. In addition, Pomalyst may not be suitable for patients with a history of severe hypersensitivity reactions to the drug or its components.
The use of Pomalyst is linked to a risk of side effects. The most common side effects of Pomalyst may include tiredness, muscle weakness, irregular bowel movements, back pain, difficulty breathing, and nausea. There are also severe risks associated with its use, such as the formation of blood clots, which may lead to heart attacks or strokes. In addition, this medication carries potential teratogenic effects in pregnancy. If you notice side effects that are persistent or worsening, promptly consult a medical professional.